[On the therapy of anoxic-hemorrhagic disorder of the CNS in the full-term and premature newborn infant].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001238:Asphyxia Neonatorum / Q000628:therapy*; D001639:Bicarbonates / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D010102:Oxygen Inhalation Therapy; D006475:Vitamin K Deficiency Bleeding / Q000628:therapy*; D014815:Vitamins / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D000697:Central Nervous System Stimulants; D014815:Vitamins
S.ulla terapia della sofferenza anossico-emorragica del S N. C. del neonato a termine ed immaturo.